Table 3. Apoptosis of PBMC from 12 healthy persons treated with triptolide (150 nmol/L, 48 h).
| Gender | Age (year) | Control (%) | T-treated (%) | |||
|---|---|---|---|---|---|---|
| Early apoptosis | Late apoptosis | Early apoptosis | Late apoptosis | |||
| 1 | M | 26 | 3.9 | 3.2 | 3.5 | 3.6 |
| 2 | M | 53 | 7.1 | 1.3 | 38.3 | 10.1 |
| 3 | F | 48 | 5.1 | 2.9 | 30.8 | 15.6 |
| 4 | M | 40 | 22.3 | 3.5 | 45.8 | 6.5 |
| 5 | M | 56 | 53.3 | 3.1 | 54.7 | 3.6 |
| 6 | M | 55 | 30.9 | 5.9 | 36.6 | 10.2 |
| 7 | M | 58 | 3.6 | 12.2 | 14.4 | 26.4 |
| 8 | F | 61 | 8.9 | 16.2 | 19.3 | 33.5 |
| 9 | F | 24 | 10.9 | 4.5 | 19.1 | 3.6 |
| 10 | M | 31 | 21.8 | 3.9 | 36.1 | 2.9 |
| 11 | M | 26 | 8.9 | 2.3 | 7.8 | 3.5 |
| 12 | M | 27 | 7.9 | 3.9 | 3.9 | 3.5 |